latest newsAppendix 4C Quarterly Report Notice of Annual General Meeting & Proxy Form 2008 Annual Report to Shareholders 2008 Co-operative Research & Development Agreement Extended LAIV data presented at 3rd European Influenza Conference Commentary on Results year end June 30 2008 Preliminary Final Report Full Year Statutory Accounts Development of protocol for commercial scale BDM-E manufacture Appendix 4C Quarterly Report Dr Andrew O'Brien appointed CEO | Investor InformationASX Announcements Financial Results
| ASX Link
|